Altimmune, Inc. (ALT) has seen some recent movement in the marketplace and its common shares closed at $13.24 yesterday. Investors are starting to take interest of ALT as the common shares traded as high as $13.69 and as low as $12.27 in the prior market trading day.
Altimmune, Inc. (ALT) average trading volume is 3.96M. However, in the prior market trading day Altimmune, Inc. (ALT) traded 1,808,850 shares. The First downside support level on ALT is $12.30 and the First resistance level on ALT is $34.94. ALT 50-day moving average is $21.07 and ALT 200day moving average is $11.15.
Altimmune, Inc. (ALT) most current performance has been shown by the recent movement in ALT common shares. ALT has performed -44.14% over the past 4 weeks, ALT has performed 72.40% over the past quarter and ALT has shown 488.44% over the past 1 year. Altimmune, Inc. (ALT) has a 1 year range of $1.51 to $35.10. Altimmune, Inc. (ALT) is trading 776.82% from its 1 year low and -62.28% from its 1 year high. Altimmune, Inc. (ALT) is indicating a 4.29% short float indicating the sum short in the float.
ALT has 32.91M shares outstanding and 23.89M shares in the float. Altimmune, Inc. (ALT) currently has a market cap of $429.90M and income of -35.70M. The EPS next quarter for ALT is -0.81 and projected EPS next year is 219.40%. The market cap of Altimmune, Inc. (ALT) at $429.90M represents how many Investors own shares of ALT and is calculated off the last price ($13.24) of ALT and the sum of shares outstanding (32.91M) with Altimmune, Inc. (ALT).
Altimmune, Inc. (ALT) has aggregate cash (mrq) of 80.23M, aggregate cash per share (mrq) of 2.46, aggregate debt of ALT stands at 2.25M and aggregate debt/equity (mrq) is 2.83. . Altimmune, Inc. (ALT) running cash flow (ttm) is -15.95M, ALT leveraged free cash flow (ttm) is -17.71M.
ALT is trading -26.35% below (bearish) its SMA20, -39.86% below (bearish) its SMA50 and 60.31% above (bullish) its SMA200.